PUBLICATIONS · 36507686
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2022 Dec 15
- First author
- Chari A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2022 Dec 15;387(24):2287-2290. doi: 10.1056/NEJMe2208708.
- note
- Source null
- related pmid
- 36507665
- relationship
- Comment in
Authors and identifiers
- name
- Chari A
- type
- Author
- name
- Minnema MC
- type
- Author
- name
- Berdeja JG
- type
- Author
- name
- Oriol A
- type
- Author
- name
- van de Donk NWCJ
- type
- Author
- name
- Rodríguez-Otero P
- type
- Author
- name
- Askari E
- type
- Author
- name
- Mateos MV
- type
- Author
- name
- Costa LJ
- type
- Author
- name
- Caers J
- type
- Author
- name
- Verona R
- type
- Author
- name
- Girgis S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chari A
- type
- Author
- name
- Minnema MC
- type
- Author
- name
- Berdeja JG
- type
- Author
- name
- Oriol A
- type
- Author
- name
- van de Donk NWCJ
- type
- Author
- name
- Rodríguez-Otero P
- type
- Author
- name
- Askari E
- type
- Author
- name
- Mateos MV
- type
- Author
- name
- Costa LJ
- type
- Author
- name
- Caers J
- type
- Author
- name
- Verona R
- type
- Author
- name
- Girgis S
- type
- Author
- bibliography ids
- nci-bib-dbbadf79559b00caac53841c
- book metadata
- content sha256
- 75b97378d40813ff6cc92a96bc58ecad68e7f45337d4bcd9cbefc46bccc42509
- document type
- citation
- dois
- 10.1056/NEJMoa2204591
- electronic publication date
- display
- 2022 Dec 10
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36507686
- immutable id
- pubmed:36507686@75b97378d40813ff6cc92a96bc58ecad68e7f45337d4bcd9cbefc46bccc42509
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 24
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 2232-2244
- volume
- 387
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2022 Dec 15;387(24):2287-2290. doi: 10.1056/NEJMe2208708.
- note
- Source null
- related pmid
- 36507665
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 36507686
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 44ae382f749c7fdfd3e1dc8534c573fed6f723093b1c1a0749a326897befbba7
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2022 Dec 15
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
Preserved source evidence · Not medical advice
Triangle